Peptide record

TPDB91756

Aurein1.2 Antibacterial Anticancer Antifungal Antiparasitic Antiviral Cell-penetrating Peptides Toxicity modified_plain modified
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB91756
Aurein1.2
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Cell-penetrating Peptides Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides Delivery and barrier-penetrating peptides
AntiBP3 dbAMP DRAMP Peptipedia AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF pep-lab Antifungipept CAFPdb AI4AVP dbAMP 3.0 DRAVP 2.0 CPPsite3.0 ToxinPred 3.0
modified_plain
Yes
A 13-aa modified multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
C-terminal: Amidation
Sequence
GLFDIIKKIAESF-NH2
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
13 reviewed residue count
Amidation Activity
L Activity
Linear Activity
Free Activity
Antimicrobial Activity
Southern bell frog Activity
Evidence Records 9 records
Evidence 1 Activity

Activity

LC50
LC50 = 10 µM
Anticancer
10 µM

Target

Breast Cancer
Breast tumor cellline
Breast

Assay & Model

Not Available
Not Available

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2000

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation. dbAMP 3.0 classified as Anticancer under the disease-associated peptide function classes.
Evidence 2 Activity

Activity

LC50
LC50=10-100 µM
Anticancer
10-100 µM

Target

Leukemia Cancer
Leukemia tumor cellline
Blood

Assay & Model

Not Available
Not Available

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2000
Evidence 3 Activity

Activity

LC50
LC50 = 10 µM
Anticancer
10 µM

Target

Lung Cancer
Lung tumor cellline
Lung

Assay & Model

Not Available
Not Available

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2000
Evidence 4 Activity

Activity

LC50
LC50 = 10 µM
Anticancer
10 µM

Target

Colon Cancer
Colon tumor cellline
Colon

Assay & Model

Not Available
Not Available

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2000
Evidence 5 Activity

Activity

LC50
LC50 = 10 µM
Anticancer
10 µM

Target

Brain Tumor
Brain tumor cellline
Brain

Assay & Model

Not Available
Not Available

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2000
Evidence 6 Activity

Activity

LC50
LC50 = 10 µM
Anticancer
10 µM

Target

Skin Cancer
Skin tumor cellline
Skin

Assay & Model

Not Available
Not Available

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2000
Evidence 7 Activity

Activity

LC50
LC50 = 10 µM
Anticancer
10 µM

Target

Ovarian Cancer
Ovary tumor cellline
Ovary

Assay & Model

Not Available
Not Available

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2000
Evidence 8 Activity

Activity

LC50
LC50 = 10 µM
Anticancer
10 µM

Target

Renal Cancer
Renal tumor cellline
Renal

Assay & Model

Not Available
Not Available

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2000
Evidence 9 Activity

Activity

LC50
LC50 = 10 µM
Anticancer
10 µM

Target

Prostate Cancer
Prostate tumor cellline
Prostate

Assay & Model

Not Available
Not Available

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2000